Cargando…

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies

Detalles Bibliográficos
Autores principales:	Allman, M., Tallantyre, E., Robertson, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919153/ https://www.ncbi.nlm.nih.gov/pubmed/35286479 http://dx.doi.org/10.1007/s00415-022-11053-7

Ejemplares similares

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
por: Willis, M. D., et al.
Publicado: (2020)

Nerve sheath tumours
por: Robertson, James A., et al.
Publicado: (2018)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021)

Uncovering SARS-CoV-2 kidney tropism
por: Musah, Samira
Publicado: (2021)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

SARS-CoV-2 bei Kindern mit Krebserkrankungen
por: Hömberg, M., et al.
Publicado: (2022)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

Kann sich SARS-CoV-2 an der Haut manifestieren?
por: Drerup, Katharina Antonia, et al.
Publicado: (2020)

Elektrische Operationsinstrumente in Zeiten der SARS-CoV2-Pandemie
por: Wolf, S., et al.
Publicado: (2020)

Seeing SARS-CoV-2 variants through the eyes of T cells
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

SARS-CoV-2-Impfung bei chronisch entzündlichen Darmerkrankungen
por: Klose, Gerald
Publicado: (2021)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
por: McArthur, C., et al.
Publicado: (2023)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

SARS-CoV-2-Pandemie steigert die Prävalenz von Gestationsdiabetes
por: Kleinwechter, Helmut
Publicado: (2022)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Gastrointestinale Manifestation und fäkale Viruslast der SARS-CoV-2-Infektion
por: Treiber, Maryam, et al.
Publicado: (2020)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

Kann Androgendeprivationstherapie eine protektive Rolle bei SARS-CoV-2-Infektionen spielen?
por: Schlack, K., et al.
Publicado: (2020)

SARS-CoV-2 ist auch besonders für Schwangere mit Diabetes sehr gefährlich
por: Kleinwechter, Helmut
Publicado: (2020)

Fallen Schwangere mit GDM während der SARS-CoV-2-Pandemie durchs Netz?
por: Kleinwechter, Helmut
Publicado: (2020)

SARS-CoV-2 – ein Update zu Hautmanifestationen, prädiktiven Markern und kutanen Impfreaktionen
por: Drerup, Katharina Antonia, et al.
Publicado: (2021)

SARS-CoV-2-Infektion und Auswirkungen auf eine nachfolgende IVF/ICSI-Behandlung
por: Goeckenjan, Maren
Publicado: (2022)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis
por: Hrastelj, James, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Socioeconomic status in neurological disorders: a modifiable risk factor?
por: Hrastelj, J., et al.
Publicado: (2022)

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts
por: M, Hu, et al.
Publicado: (2020)

Preclinical retinal neurodegeneration in a model of multiple sclerosis: The Journal of Neuroscience 2012; 32(16):5585–5597
por: Mathur, Deepali, et al.
Publicado: (2012)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
por: Tiwari, Vivekanand, et al.
Publicado: (2021)

Eine Impfung gegen Multiple Sklerose?
por: Limmroth, Volker
Publicado: (2021)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Technology-assisted recovery of walking after spinal cord injury
por: MD, Willis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ar349l04h8entk88e9r5a6vv8